INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions incl...

Full description

Saved in:
Bibliographic Details
Main Authors DING, Fa-Xiang, DONG, Shuzhi, JIANG, Jinlong, PIO, Barbara, CHOBANIAN, Harry, WALSH, Shawn, P, KIM, Dooseop, GUO, Yan
Format Patent
LanguageEnglish
French
German
Published 07.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.
AbstractList The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.
Author KIM, Dooseop
PIO, Barbara
JIANG, Jinlong
DING, Fa-Xiang
WALSH, Shawn, P
GUO, Yan
CHOBANIAN, Harry
DONG, Shuzhi
Author_xml – fullname: DING, Fa-Xiang
– fullname: DONG, Shuzhi
– fullname: JIANG, Jinlong
– fullname: PIO, Barbara
– fullname: CHOBANIAN, Harry
– fullname: WALSH, Shawn, P
– fullname: KIM, Dooseop
– fullname: GUO, Yan
BookMark eNrjYmDJy89L5WSw9PTz8HTyDPEPClbwd1MI8XBVCHL1c_RR8A8NcQ1S8HV1CfXxcQyKVAjwD3EMDvYM9VVw9nD083P14WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxgYWxqbmxk6GxkQoAQBPYCpB
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DU CANAL POTASSIQUE MÉDULLAIRE EXTERNE RÉNAL
INHIBITOREN DES RENALEN KALIUMKANALS DER ÄUSSEREN MEDULLA
ExternalDocumentID EP3083573B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3083573B13
IEDL.DBID EVB
IngestDate Fri Aug 16 05:52:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3083573B13
Notes Application Number: EP20140870698
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240807&DB=EPODOC&CC=EP&NR=3083573B1
ParticipantIDs epo_espacenet_EP3083573B1
PublicationCentury 2000
PublicationDate 20240807
PublicationDateYYYYMMDD 2024-08-07
PublicationDate_xml – month: 08
  year: 2024
  text: 20240807
  day: 07
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Merck Sharp & Dohme LLC
RelatedCompanies_xml – name: Merck Sharp & Dohme LLC
Score 3.5538616
Snippet The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240807&DB=EPODOC&locale=&CC=EP&NR=3083573B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPkVmweNskhSB4bEsmLmEg9lTTJQi9psRH_vrMhrV70NuzCMjsws9-3OzML8IAonlWSWCBNXSoThUtFyZC4FkxV5Qohhcxrh8No5uXKy_xpPoDVrham6xP61TVHRI8q0d_bLl5vfi6xnC63cvu4XOHQ-tnNDEfo2THv1zVVBccyaBI7sS3YNkpClBoyhxqqbCFROkAUrXJnoG8WL0rZ_D5R3FM4THCxpj2DQd2M4Njefbw2gqOwf-9GsXe97TnofuT5lp_F6SuJXZJ5lKQ0MgMS54hISUidPAjM9J0kcWZiiMxDYntmFNHgAohLM9uboA6L_X4XNNlrK1_CsFk39RUQZL0zUauYXiAj0yRFK5muVHJVixqTpHI6hvGfy1z_M3cDJ9xwXVKbegvD9uOzvsODtl3edyb6Bj71fN4
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2J97kFyKzaPNumhSB4bEk02ISZSTyHNA3pJi434950NbfWit2EXltmBmf2-3ZlZgAdE8VUhiRnS1IUyVLiU5RUS16xSVblASCHz2mGfTZxEeZ6P5x1Y7mph2j6hX21zRPSoHP29aeP1-ucSy2pzKzePiyUOrZ7seGYJW3bM-3WNVMEyZjQMrMAUTBMlgUUzmUMNVTaQKB0gwla5M9A3gxelrH-fKPYJHIa4WN2cQqes-9Azdx-v9eHI3753o7h1vc0ZTF3muIYbB9ErCWwSO5RElOkeCRJEpMSnVuJ5evROwiDWMUQmPjEdnTHqnQOxaWw6Q9Qh3e83peFeW_kCuvWqLi-BIOudiFpRTTNkZJqkaHk1VQq5KEWtkqR8NIDBn8tc_TN3Dz0n9r3Uc9nLNRxzI7YJbuoNdJuPz_IWD91mcdea6xtFLH_R
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INHIBITORS+OF+THE+RENAL+OUTER+MEDULLARY+POTASSIUM+CHANNEL&rft.inventor=DING%2C+Fa-Xiang&rft.inventor=DONG%2C+Shuzhi&rft.inventor=JIANG%2C+Jinlong&rft.inventor=PIO%2C+Barbara&rft.inventor=CHOBANIAN%2C+Harry&rft.inventor=WALSH%2C+Shawn%2C+P&rft.inventor=KIM%2C+Dooseop&rft.inventor=GUO%2C+Yan&rft.date=2024-08-07&rft.externalDBID=B1&rft.externalDocID=EP3083573B1